Skip to Main Content

Paper Details

Intravitreal Nesvacumab (Anti-Angiopoietin-2) Plus Aflibercept in Neovascular AMD: Phase 2 ONYX Randomized Trial.
J Vitreoretin Dis
4
2022
Author NameAffiliation
Allen C HoWills Eye Hospital
  • 1 - 1

Datasets

Release 1.2